Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Ovid Therapeutics (NASDAQ: OVID)
Follow
NASDAQ:OVID
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
OVID
Ovid Therapeutics
LEVIN JEREMY M
/
director, officer: CEO
03/18/2024
Buy
$2.76
18,248
$50K
3.62M
NASDAQ
OVID
Ovid Therapeutics
Tardio Jason
/
officer: Chief Operating Officer
02/22/2024
Buy
$3.68
168,750
$621K
168,750
NASDAQ
OVID
Ovid Therapeutics
Rona Jeffrey A
/
officer: CBFO
02/22/2024
Buy
$3.68
168,750
$621K
0
NASDAQ
OVID
Ovid Therapeutics
Poole Robert Michael
/
director
02/22/2024
Buy
$3.68
30,000
$110K
30,000
NASDAQ
OVID
Ovid Therapeutics
Perone Thomas Michael
/
officer: General Counsel, Secretary
02/22/2024
Buy
$3.68
168,750
$621K
168,750
NASDAQ
OVID
Ovid Therapeutics
LEVIN JEREMY M
/
director, officer: CEO
02/22/2024
Buy
$3.68
700,000
$2.576M
700,000
NASDAQ
OVID
Ovid Therapeutics
Friedman Bart
/
director
02/22/2024
Buy
$3.68
30,000
$110K
30,000
NASDAQ
OVID
Ovid Therapeutics
Fitzgerald Kevin Joseph
/
director
02/22/2024
Buy
$3.68
30,000
$110K
30,000
NASDAQ
OVID
Ovid Therapeutics
Duncan Barbara Gayle
/
director
02/22/2024
Buy
$3.68
30,000
$110K
30,000
NASDAQ
OVID
Ovid Therapeutics
Bernstein Karen
/
director
02/22/2024
Buy
$3.68
30,000
$110K
30,000
NASDAQ
OVID
Ovid Therapeutics
Tardio Jason
/
officer: Chief Operating Officer
02/23/2023
Buy
$2.50
175,000
$438K
175,000
NASDAQ
OVID
Ovid Therapeutics
Rona Jeffrey A
/
officer: CBFO
02/23/2023
Buy
$2.50
175,000
$438K
175,000
NASDAQ
OVID
Ovid Therapeutics
Poole Robert Michael
/
director
02/23/2023
Buy
$2.50
15,000
$38K
15,000
NASDAQ
OVID
Ovid Therapeutics
Perone Thomas Michael
/
officer: General Counsel, Secretary
02/23/2023
Buy
$2.50
175,000
$438K
175,000
NASDAQ
OVID
Ovid Therapeutics
LEVIN JEREMY M
/
director, 10 percent owner, officer: CEO
02/23/2023
Buy
$2.50
600,000
$1.500M
600,000
NASDAQ
OVID
Ovid Therapeutics
Friedman Bart
/
director
02/23/2023
Buy
$2.50
15,000
$38K
15,000
NASDAQ
OVID
Ovid Therapeutics
Fitzgerald Kevin Joseph
/
director
02/23/2023
Buy
$2.50
15,000
$38K
15,000
NASDAQ
OVID
Ovid Therapeutics
Duncan Barbara Gayle
/
director
02/23/2023
Buy
$2.50
15,000
$38K
15,000
NASDAQ
OVID
Ovid Therapeutics
Bernstein Karen
/
director
02/23/2023
Buy
$2.50
15,000
$38K
15,000
NASDAQ
OVID
Ovid Therapeutics
Tardio Jason
/
officer: Chief Operating Officer
09/12/2022
Sell
$2.15
17,344
$37K
0
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.
